Sarda Proteins Ltd

Sarda Proteins Ltd has seen its investment rating upgraded from Strong Sell to Sell, driven primarily by a shift in technical indicators despite ongoing fundamental challenges. The edible oil company’s technical trend has improved to mildly bullish, prompting a reassessment of its market stance, even as financial performance remains subdued and valuation concerns persist.

Sarda Proteins Ltd, a micro-cap player in the edible oil sector, has seen its investment rating downgraded from Sell to Strong Sell as of 31 August 2026. This shift reflects deteriorating technical indicators, flat financial performance, and weak fundamental metrics, signalling heightened risk for investors amid a challenging market environment.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 18 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and overall outlook.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 03 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 07 August 2026, providing investors with the latest insights into its performance and outlook.

Sarda Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Sarda Proteins Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 13 July 2026, driven primarily by a shift in technical indicators despite persistent fundamental weaknesses. The edible oil micro-cap’s recent quarterly financials showed positive momentum, but valuation and long-term financial trends remain a concern for investors.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 July 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 09 July 2026, providing investors with the latest insights into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Sarda Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Sarda Proteins Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 17 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trends, and technical outlook.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 May 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 15 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Sarda Proteins Ltd, a micro-cap player in the edible oil sector, has witnessed a significant shift in its valuation parameters, prompting a reassessment of its price attractiveness. Despite a robust five-year return of 350.56%, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios have surged to levels that challenge traditional valuation norms, raising concerns among investors and analysts alike.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 12 Nov 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are current as of 21 April 2026, providing investors with the latest view of the company’s performance and prospects.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 10 April 2026, providing investors with the latest insights into its performance and outlook.

Sarda Proteins Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 12 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 30 March 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.